These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Deciphering mechanisms of action of ACE inhibitors in neurodegeneration using Ghalayini J; Boulianne GL Front Neurosci; 2023; 17():1166973. PubMed ID: 37113150 [TBL] [Abstract][Full Text] [Related]
3. Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer's disease: Past, present and future. Gouveia F; Camins A; Ettcheto M; Bicker J; Falcão A; Cruz MT; Fortuna A Ageing Res Rev; 2022 May; 77():101612. PubMed ID: 35346852 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin IV Receptors Mediate the Cognitive and Cerebrovascular Benefits of Losartan in a Mouse Model of Alzheimer's Disease. Royea J; Zhang L; Tong XK; Hamel E J Neurosci; 2017 May; 37(22):5562-5573. PubMed ID: 28476949 [TBL] [Abstract][Full Text] [Related]
5. The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer's disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status. Ouk M; Wu CY; Rabin JS; Jackson A; Edwards JD; Ramirez J; Masellis M; Swartz RH; Herrmann N; Lanctôt KL; Black SE; Swardfager W Alzheimers Res Ther; 2021 Feb; 13(1):43. PubMed ID: 33573702 [TBL] [Abstract][Full Text] [Related]
6. Renin-Angiotensin System and Alzheimer's Disease Pathophysiology: From the Potential Interactions to Therapeutic Perspectives. Ribeiro VT; de Souza LC; Simões E Silva AC Protein Pept Lett; 2020; 27(6):484-511. PubMed ID: 31886744 [TBL] [Abstract][Full Text] [Related]
7. Impact of renin-angiotensin system-targeting antihypertensive drugs on treatment of Alzheimer's disease: a meta-analysis. Ye R; Hu Y; Yao A; Yang Y; Shi Y; Jiang Y; Zhang J Int J Clin Pract; 2015 Jun; 69(6):674-81. PubMed ID: 25721930 [TBL] [Abstract][Full Text] [Related]
8. Brain angiotensin II and angiotensin IV receptors as potential Alzheimer's disease therapeutic targets. Royea J; Hamel E Geroscience; 2020 Oct; 42(5):1237-1256. PubMed ID: 32700176 [TBL] [Abstract][Full Text] [Related]
10. A novel design of combining the angiotensin converting enzyme (ACE) inhibitor captopril with the angiotensin receptor blocker (ARB) losartan using homo coupling via PEG diacid linker. Hashemzadeh M; Park S; Ju H; Movahed MR Recent Pat Cardiovasc Drug Discov; 2013 Dec; 8(3):221-5. PubMed ID: 24552291 [TBL] [Abstract][Full Text] [Related]
11. Comparative studies on differential inhibition of the renin - angiotensin system in the anesthetized guinea pig. Duan J; Jaramillo J; Jung GL; McLeod AL; Fernandes BH; Mathis D Can J Physiol Pharmacol; 1995 Oct; 73(10):1512-8. PubMed ID: 8748944 [TBL] [Abstract][Full Text] [Related]
12. Research Progress of Alzheimer's Disease Therapeutic Drugs: Based on Renin-Angiotensin System Axis. Li X; Xuan W; Chen D; Gao H; Wang G; Guo Q; Wang Y; Song H; Cai B J Alzheimers Dis; 2020; 78(4):1315-1338. PubMed ID: 33164932 [TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of angiotensin modulators according to Oliveira FF; Almeida SS; Chen ES; Smith MC; Bertolucci PHF Acta Neuropsychiatr; 2023 Dec; 35(6):346-361. PubMed ID: 37605989 [TBL] [Abstract][Full Text] [Related]
14. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism. Haddad G; Amiri F; Garcia R Regul Pept; 1997 Jan; 68(2):111-7. PubMed ID: 9110382 [TBL] [Abstract][Full Text] [Related]
15. The renin-angiotensin system: the role of inhibitors, blockers, and genetic polymorphisms in the treatment and prevention of heart failure. Hebert PR; Foody JM; Hennekens CH Curr Vasc Pharmacol; 2003 Mar; 1(1):33-9. PubMed ID: 15320851 [TBL] [Abstract][Full Text] [Related]
16. The calcineurin inhibitor Sarah (Nebula) exacerbates Aβ42 phenotypes in a Drosophila model of Alzheimer's disease. Lee S; Bang SM; Hong YK; Lee JH; Jeong H; Park SH; Liu QF; Lee IS; Cho KS Dis Model Mech; 2016 Mar; 9(3):295-306. PubMed ID: 26659252 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin Converting Enzyme Inhibitors Ameliorate Brain Inflammation Associated with Microglial Activation: Possible Implications for Alzheimer's Disease. Torika N; Asraf K; Roasso E; Danon A; Fleisher-Berkovich S J Neuroimmune Pharmacol; 2016 Dec; 11(4):774-785. PubMed ID: 27562846 [TBL] [Abstract][Full Text] [Related]
18. Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers. Ouk M; Wu CY; Rabin JS; Edwards JD; Ramirez J; Masellis M; Swartz RH; Herrmann N; Lanctôt KL; Black SE; Swardfager W; Neurobiol Aging; 2021 Apr; 100():22-31. PubMed ID: 33461049 [TBL] [Abstract][Full Text] [Related]
19. [Alzheimer disease--contribution of renin-angiotensin system to Alzheimer disease progression]. Ohrui T Nihon Rinsho; 2012 Sep; 70(9):1599-603. PubMed ID: 23012810 [TBL] [Abstract][Full Text] [Related]
20. Comparative studies on the memory-enhancing actions of captopril and losartan in mice using inhibitory shock avoidance paradigm. Raghavendra V; Chopra K; Kulkarni SK Neuropeptides; 2001 Feb; 35(1):65-9. PubMed ID: 11346312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]